Sharon M Weber, MD, FACS
- Chief, Division of Surgical Oncology
- Medical Director of Surgical Oncology, UW Carbone Cancer Center
- Endowed Professor, Tim and Mary Ann McKenzie Professorship in Surgical Oncology
600 Highland Avenue
Box 7375 Clinical Science Center
Madison, Wisconsin 53792-3284
- MD, University of Wisconsin Medical School, Madison, WI, 1993
- Residency in General Surgery, University of Wisconsin Hospital and Clinics, Madison, WI, 1993-1999
- Research Fellowship in Tumor Immunotherapy, University of Wisconsin Medical School, Madison, WI, 1996-1997
- Surgical Oncology Fellowship, Memorial Sloan-Kettering Cancer Center, New York, NY, 1999-2001
- Hepatobiliary Fellowship, Memorial Sloan-Kettering Cancer Center, New York, NY, 2000-2001
Dr. Weber is actively involved in minimally invasive approaches to cancer treatment, including both laparoscopic pancreas and liver surgery. She has been invited as a speaker/moderator at many national meetings, including the American College of Surgeons, the American Hepatopancreaticobiliary Association, Society of Surgical Oncology, and Society of University Surgeons.
Dr. Weber provides a wide range of services including Bile Duct Resection, Caudate Resection, Cryoablation, Cyst Fenestration (Unroof Liver Cyst), Cytoreductive Surgery with HIPEC, Frey Procedure, Gastrectomy – Partial or Total, Hemihepatectomy (Hepatectomy), Laparoscopic Liver Resection, Liver Resection, Liver Tumor Ablations, Melanoma Completion Lymph Node Dissection (Axillary and Groin), Melanoma Sentinel Lymph Node Biopsy, Melanoma Wide Local Excision and Skin Closure, Obstructed Pancreatic Duct Drainage (Peustow Procedure), Pancreatic Head Resection, Pancreaticoduodenectomy, Pancreatic Pseudocysts Drainage, Pancreatic Resections, Radical Cholecystectomy, Radiofrequency Ablation, Right Hemihepatectomy, Right / Left Extended Hemihepatectomy (Hepatectomy), Wedge Resection of the Liver, Whipple Procedure.
Dr. Weber conducts translational research at the UW Carbone Cancer Center evaluating novel tumor selective agents which may be promising for imaging and/or treating tumors. She also conducts clinical research evaluating prognosticators of outcome in patients with liver, bile duct, and liver tumors.
- Natural History and Treatment Trends in Pancreatic Cancer Subtypes.
- Pokrzywa CJ, Abbott DE, Matkowskyj KA, Ronnekleiv-Kelly SM, Winslow ER, Weber SM, Fisher AV
- J. Gastrointest. Surg. 2019 Jan 31;
- [PubMed ID: 30706376]
- Predictive Value of Chromogranin A and a Pre-Operative Risk Score to Predict Recurrence After Resection of Pancreatic Neuroendocrine Tumors.
- Fisher AV, Lopez-Aguiar AG, Rendell VR, Pokrzywa C, Rocha FG, Kanji ZS, Poultsides GA, Makris EA, Dillhoff ME, Beal EW, Fields RC, Panni RZ, Idrees K, Smith PM, Cho CS, Beems MV, Maithel SK, Winslow ER, Abbott DE, Weber SM
- J. Gastrointest. Surg. 2019 Jan 18;
- [PubMed ID: 30659439]
- Staging laparoscopy among three subtypes of extra-hepatic biliary malignancy: a 15-year experience from 10 institutions.
- Davidson JT, Jin LX, Krasnick B, Ethun CG, Pawlik TM, Poultsides GA, Idrees K, Weber SM, Martin RCG, Shen P, Hatzaras I, Maithel SK, Fields RC, and the U.S. Extrahepatic Biliary Malignancy Consortium
- J Surg Oncol 2019 Mar; 119(3): 288-294
- [PubMed ID: 30586170]
- Deficiencies in postoperative surveillance for veterans with gastrointestinal cancer.
- Taylor LJ, Xu K, Maloney JD, Voils CI, Weber SM, Funk LM, Abbott DE
- J Surg Oncol 2019 Mar; 119(3): 273-277
- [PubMed ID: 30554412]
- Actual 5-Year Survivors After Surgical Resection of Hilar Cholangiocarcinoma.
- Tran TB, Ethun CG, Pawlik TM, Schmidt C, Beal EW, Fields RC, Krasnick B, Weber SM, Salem A, Martin RCG, Scoggins CR, Shen P, Mogal HD, Idrees K, Isom CA, Hatzaras I, Shenoy R, Maithel SK, Poultsides GA
- Ann. Surg. Oncol. 2019 Feb; 26(2): 611-618
- [PubMed ID: 30539494]